Lexicon Pharmaceuticals/ US5288723027 /
| 12/1/2023 9:59:55 PM | Chg. +0.07 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 1.15USD | +6.48% | 22,565 Turnover: 25,302.22 |
-Bid Size: - | -Ask Size: - | 1.16 | 1.05 |
GlobeNewswire
3/21/2022
New Analysis of Cardiovascular Endpoints in the SCORED Trial to Be Presented at the American College...
GlobeNewswire
3/17/2022
Lexicon Enters Into Loan Facility With Oxford Finance for Up to $150 Million to Support Planned Comm...
GlobeNewswire
3/13/2022
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lexicon Pharmace...
GlobeNewswire
3/5/2022
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lexicon Pharmace...
GlobeNewswire
2/28/2022
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Cli...
GlobeNewswire
2/26/2022
Lexicon Pharmaceuticals to Host Fourth Quarter 2021 Financial Results Conference Call and Webcast on...
GlobeNewswire
1/13/2022
Lexicon Pharmaceuticals Outlines Major Potential Value Drivers for 2022 at 40th Annual J.P. Morgan H...
GlobeNewswire
1/4/2022
Lexicon Pharmaceuticals to Participate in The 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire
12/30/2021
Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults ...
GlobeNewswire
11/15/2021
Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare Conference and the Piper S...
GlobeNewswire
11/14/2021
Lexicon’s Sotagliflozin Demonstrates Benefits in Heart Failure and Blood Glucose Control Across the ...
GlobeNewswire
11/9/2021
New Analysis to be Presented at the American Heart Association Scientific Sessions 2021 Evaluating C...
GlobeNewswire
11/8/2021
Caribou Biosciences Appoints Dara Richardson-Heron, M.D., to its Board of Directors and Ruhi Khan as...
GlobeNewswire
11/3/2021
Lexicon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical Update
GlobeNewswire
10/29/2021
Lexicon Pharmaceuticals to Host Third Quarter 2021 Financial Results Conference Call and Webcast on ...
GlobeNewswire
9/15/2021
Lexicon Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
GlobeNewswire
8/30/2021
Lexicon Welcomes New ESC Heart Failure Treatment Guidelines Establishing SGLT Inhibitors as Standard...
GlobeNewswire
8/23/2021
Lexicon’s Sotagliflozin Demonstrates Additional Compelling Benefits in Reducing Cardiovascular Endpo...
GlobeNewswire
7/30/2021
Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical Officer
GlobeNewswire
7/30/2021
Lexicon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical Update
GlobeNewswire
7/28/2021
Lexicon Pharmaceuticals to Host Second Quarter 2021 Financial Results Conference Call and Webcast on...